Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
India levels up in solving complex drug formulation challenges
Chetan Shah highlights how India’s pharmaceutical industry is advancing from bulk drug production to complex formulations,…
Alzheimer’s disease market to reach $17 billion in 8MM by 2033, forecasts GlobalData
GlobalData projects disease-modifying therapies, ageing populations, and new symptomatic treatments to drive Alzheimer’s disease…
Extrovis AG and Dr Reddy’s launch authorised generic Fluorouracil Cream 0.5 per cent in US market
The authorised generic of Carac (fluorouracil cream) 0.5 per cent is approved by the USFDA and manufactured in Texas for the…
NATCO Pharma launches generic Bosentan tablets for oral suspension in the United States
NATCO partners with Lupin for Bosentan tablets, gains 180-day exclusivity for pulmonary arterial hypertension treatment in…
BioMed X and Novo Nordisk launch collaboration on oral peptide drug delivery
The partnership will focus on developing oral formulation technologies to improve absorption and bioavailability of peptide-based…
IQVIA India secures CDSCO CRO registration, reinforces leadership in clinical research
IQVIA India’s CDSCO CRO registration reinforces its role in strengthening clinical trial standards and supporting India’s growing…
Cholrem study shows cyclodextrin-based therapy Cavadex reverses atherosclerotic cardiovascular…
Peer-reviewed research in Cardiology Research and Cardiovascular Medicine reports regression of arterial plaque and symptom relief…
CCRAS and WHO-SEARO conduct regional workshop on WHO-GMP for herbal medicines in Mumbai
Four-day workshop from 19–22 August 2025 brings together international delegates and Indian experts to discuss good manufacturing…
Valkit.ai announces strategic partnership with Life Science Consulting
Generation 2 digital validation platform expands global reach through alliance with 25-year industry leader serving 200+…
Alembic Pharmaceuticals receives USFDA approval for Macitentan Tablets, 10 mg
Alembic Pharmaceuticals secures final approval for its ANDA Macitentan Tablets, a therapeutic equivalent of Actelion’s Opsumit,…